Role of investigational new drug committees in propelling the drug development ecosystem in India.
作者信息
Davis Sanish
机构信息
President, Indian Society for Clinical Research, Mumbai, India.
出版信息
Perspect Clin Res. 2021 Oct-Dec;12(4):177-178. doi: 10.4103/picr.picr_190_21. Epub 2021 Sep 20.
Abstract
摘要
相似文献
1
Role of investigational new drug committees in propelling the drug development ecosystem in India.研究性新药委员会在推动印度药物开发生态系统中的作用。
Perspect Clin Res. 2021 Oct-Dec;12(4):177-178. doi: 10.4103/picr.picr_190_21. Epub 2021 Sep 20.
2
How to ascertain drug related deaths during clinical trials ?
J Assoc Physicians India. 2013 Oct;61(10):733-7.
3
A Bayesian dose-finding trial with adaptive dose expansion to flexibly assess efficacy and safety of an investigational drug.贝叶斯剂量探索试验结合适应性剂量扩展，灵活评估试验药物的疗效和安全性。
Clin Trials. 2010 Apr;7(2):121-35. doi: 10.1177/1740774510361541. Epub 2010 Mar 25.
4
Investigational drugs and research.研究性药物与研究
Psychiatr Med. 1991;9(2):333-47.
5
Post-trial access to investigational drugs in India: addressing challenges in the regulatory framework.印度试验后获取研究用药物：解决监管框架中的挑战。
Med Law Rev. 2024 Feb 26;32(1):20-41. doi: 10.1093/medlaw/fwad028.
6
[Reorganization of the procedures and the tasks of the responsible ethics committees after the 12th AMG amendment. Concepts of the permanent working group of the medical ethics committees in Germany].[第12次《社会法典》第五编修订后负责伦理委员会的程序与任务重组。德国医学伦理委员会常设工作组的概念]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Feb;48(2):155-67. doi: 10.1007/s00103-004-0981-6.
7
Drug companies cut costs with foreign clinical trials.制药公司通过国外临床试验削减成本。
N Y Times Web. 2005 Feb 24:C4.
8
Are village health sanitation and nutrition committees fulfilling their roles for decentralised health planning and action? A mixed methods study from rural eastern India.乡村卫生、环境卫生与营养委员会在分权式卫生规划和行动中是否发挥了作用？一项来自印度东部农村地区的混合方法研究。
BMC Public Health. 2016 Jan 22;16:59. doi: 10.1186/s12889-016-2699-4.
9
[Therapeutic uses of investigational drugs: research extension, compassionate use, and expanded access].[研究性药物的治疗用途：研究扩展、同情用药和扩大获取]
Rev Panam Salud Publica. 2008 Mar;23(3):198-206. doi: 10.1590/s1020-49892008000300007.
10
Recommendations from the Investigational New Drug/Investigational Device Exemption Task Force of the clInical and Translational Science Award Consortium: developing and implementing a sponsor-investigators training program.临床与转化科学奖联盟新药临床试验申请/研究器械豁免工作组的建议：制定并实施申办者-研究者培训计划。
J Investig Med. 2014 Jun;62(5):797-803. doi: 10.2310/JIM.0000000000000083.
本文引用的文献
1
A two-year evaluation of the minutes of Investigational New Drug committee meetings.对研究性新药委员会会议记录的两年评估。
Perspect Clin Res. 2021 Oct-Dec;12(4):199-202. doi: 10.4103/picr.PICR_83_19. Epub 2020 May 7.
2
Regulatory requirements for clinical trials in India: What academicians need to know.印度临床试验的监管要求：院士需要了解的内容。
Indian J Anaesth. 2017 Mar;61(3):192-199. doi: 10.4103/ija.IJA_143_17.
Zotero 插件